Scorpiglione N, Nicolucci A, Grilli R, Angiolini C, Belfiglio M, Carinci F, Cubasso D, Filardo G, Labbrozzi D, Mainini F
Laboratorio di Farmacologia Clinica ed Epidemiologia Consorzio Mario Negri Sud (S. Maria Imbaro, Chieti), Italy.
J Clin Epidemiol. 1995 Mar;48(3):345-52. doi: 10.1016/0895-4356(94)00148-j.
To assess appropriateness of surgical care delivered to breast cancer patients in Italy and quantify the use of unnecessary radical procedures, a retrospective charts review of patients treated in 1988-1989 was conducted. A series of 1724 consecutive patients (median age 61 years; range 17-89) treated in 63 hospitals selected from within 8 regions with newly diagnosed operable breast carcinoma was evaluated. Overall, 541 (38%) patients had inappropriate surgery with more than two thirds of it being accounted for by the use of unnecessary mutilating Halsted mastectomy. Substantial geographic variation emerged in the overall rates of appropriateness (range 88-52%) which were not substantially affected by allowance for imbalances in patient- and hospital-related variables. Despite the important contribution given by Italian clinical researchers to the demonstration that less radical surgery can be as good as more radical procedures, still a substantial proportion of breast cancer patients are treated too aggressively. Besides pointing to the urgent need of interventions aimed at facilitating the process of technology transfer in order to promote more appropriate surgical care, these results suggest that efforts to increase patients' participation into treatment decision and awareness about alternative treatment options are warranted.
为评估意大利乳腺癌患者接受手术治疗的适宜性,并量化不必要的根治性手术的使用情况,对1988 - 1989年接受治疗的患者进行了回顾性病历审查。评估了从8个地区选出的63家医院中连续治疗的1724例患者(中位年龄61岁;范围17 - 89岁),这些患者均为新诊断的可手术乳腺癌患者。总体而言,541例(38%)患者接受了不适当的手术,其中超过三分之二是由于使用了不必要的致残性哈尔斯特德乳房切除术。适宜性总体发生率出现了显著的地理差异(范围88% - 52%),在考虑患者和医院相关变量不平衡的情况下,这种差异并未受到实质性影响。尽管意大利临床研究人员在证明不太激进的手术与更激进的手术效果相当方面做出了重要贡献,但仍有相当比例的乳腺癌患者接受了过于激进的治疗。这些结果除了表明迫切需要采取干预措施以促进技术转移过程,从而推动更适宜的手术治疗外,还表明有必要努力提高患者对治疗决策的参与度以及对替代治疗方案的认识。